ChartRow logo
Data provided bySource: Twelve Data
ROIV
$38.71+0.26%
as of close, Nov 17, 2026
☾ AH $38.71 +0.26%
Share this page

ROIV financial statements

The full income statement, balance sheet, and cash-flow statement for Roivant Sciences Ltd. (ROIV), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR −19.1%5Y CAGR −19.1%YoY +2135.6%
$41.1M TTM$35.1M Q2 '26
FY20FY21FY22FY23FY24FY25TTM
Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Operating income

5Y n/m5Y n/mYoY n/m
−$558M TTM−$268M Q2 '26
FY20FY21FY22FY23FY24FY25TTM
Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Net income

5Y n/m5Y n/mYoY n/m
−$344.4M TTM−$191.6M Q2 '26
FY20FY21FY22FY23FY24FY25TTM
Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

EPS (diluted)

5Y n/m5Y n/mYoY n/m
−$0.48 TTM−$0.27 Q2 '26
FY20FY21FY22FY23FY24FY25TTM
Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Operating cash flow

5Y n/m5Y n/mYoY n/m
−$36.4M TTM$594.4M Q2 '26
FY20FY21FY22FY23FY24FY25TTM
Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Capital expenditure

5Y CAGR +7.2%5Y CAGR +7.2%YoY −97.3%
$3M TTM$208K Q2 '26
FY20FY21FY22FY23FY24FY25TTM
Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Free cash flow

5Y n/m5Y n/mYoY n/m
−$33.3M TTM$594.2M Q2 '26
FY20FY21FY22FY23FY24FY25TTM
Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Shares (diluted)

5Y +10.1%5Y +10.1%YoY +6.1%
714.4M TTM722.8M Q2 '26
FY20FY21FY22FY23FY24FY25TTM
Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Every ROIV chart on Trends →

Shares outstanding (point-in-time)

2024-09 727.9M2024-12 713.5M2025-03 679.8M2025-06 682.9M2025-09 695.5M2025-12 715.7M2026-03 719.3M2026-06 722.3M2026-09 724.6M-0.5% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Revenue8.26M-71.6%29.1M-11.2%32.7M+3.8%31.5M-43.0%55.3M+132.3%
1.29B+13.2%1.14B+29.3%884M-5.8%938M-33.3%1.41B+28.5%
Research & development682M+23.9%550M+25.1%440M-3.1%454M-6.0%483M+104.1%
Selling, general & administrative610M+3.2%591M+42.1%416M+8.5%383M-50.5%775M+198.2%
General & administrative610M+3.2%591M+42.1%416M+8.5%383M-50.5%775M+198.2%
Operating income-515M+48.7%-1.00B-122.3%4.50B+595.9%-907M+32.9%-1.35B-26.2%
Interest expense——34.8M+24.3%28.0M+297.2%7.04M+150.7%
Interest & investment income178M-31.1%258M+76.5%146M——
Other non-operating income4.01M+137.4%-10.7M+20.9%-13.6M-2690.5%-486K-115.0%3.24M+137.2%
Equity-method income
————0.00+100.0%
Pre-tax income-265M+61.2%-682M-114.9%4.57B+616.1%-885M+4.2%-924M-2.8%
Income tax133M+176.8%48.2M+124.0%21.5M+426.8%4.08M+1006.2%369K-78.1%
-300M-74.3%-172M-104.0%4.35B+531.0%-1.01B-19.4%-845M-4.5%
Income from continuing operations-300M+45.0%-545M-111.7%4.66B+694.5%-784M+7.2%-845M-4.5%
Discontinued operations0.00-100.0%373M+218.4%-315M-39.2%-226M0.00
Net income to non-controlling interest-98.1M+46.9%-185M-56.9%-118M-10.6%-106M-35.0%-78.9M+13.3%
Net income to common-300M-74.3%-172M-104.0%4.35B+531.0%-1.01B-19.4%-845M-4.5%
-$0.54-125.0%-$0.24-104.6%$5.23+468.3%-$1.42-12.7%-$1.26+1.6%
EPS (basic)-$0.43-79.2%-$0.24-104.3%$5.55+490.8%-$1.42-12.7%-$1.26+1.6%
Weighted-avg shares (basic)694M-4.3%725M-7.4%783M+9.9%713M+6.4%670M+6.3%
Weighted-avg shares (diluted)694M-4.3%725M-12.7%831M+16.6%713M+6.4%670M+6.3%
Balance Sheetas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
5.17B+3.3%5.00B-25.7%6.73B+274.3%1.80B-16.2%2.15B-1.9%
Cash & equivalents1.42B-47.7%2.72B-58.2%6.49B+287.3%1.68B-18.6%2.06B+0.3%
Short-term investments2.87B+32.3%2.17B0.00——
Cash & short-term investments4.29B-12.2%4.89B-24.8%6.49B——
Accounts receivable——3.99M-86.9%30.4M+683.4%3.88M-65.4%
Inventory——35.3M+1176.7%2.76M0.00
Prepaid expenses——33.8M-44.5%60.8M+14.0%53.4M+35.0%
Other current assets105M-6.9%113M+40.4%80.6M-33.8%122M+41.4%86.1M+58.8%
5.71B+5.0%5.44B-24.7%7.22B+202.2%2.39B-7.6%2.59B-0.2%
Property, plant & equipment12.0M-0.6%12.1M-21.3%15.3M-60.8%39.1M+50.9%25.9M+75.6%
Operating lease right-of-use80.4M-9.7%89.0M+102.3%44.0M-17.4%53.3M-12.8%61.0M-2.0%
Intangible assets——138M-4.9%145M0.00
Long-term investments
————0.00-100.0%
Other non-current assets40.9M+24.5%32.9M-12.8%37.7M-23.8%49.5M+91.6%25.8M-5.1%
281M+88.2%149M-44.0%267M-2.1%272M+47.8%184M-15.8%
Accounts payable18.0M-24.0%23.7M+68.9%14.0M-62.9%37.8M+9.4%34.6M+68.3%
Accrued liabilities206M+80.1%114M-4.3%119M-28.5%167M+31.0%128M+65.8%
Deferred revenue—1.17M-72.0%4.17M-66.5%12.4M+22.6%10.1M+71.5%
Short-term & current debt——12.0M-70.5%40.7M0.00
Current lease liability11.1M+13.3%9.84M+9.8%8.97M-23.3%11.7M+2.6%11.4M-7.4%
Other current liabilities583K-50.1%1.17M-91.6%13.9M-7.5%15.1M+38.9%10.9M+234.6%
Finance lease liability (current)
———2.09M—
416M+66.7%250M-67.7%774M-1.0%782M+49.3%524M-0.8%
Long-term debt——431M+14.7%376M+78.8%210M+23.3%
Deferred revenue (non-current)
————13.7M
Non-current lease liability96.3M+6.6%90.3M+100.6%45.0M-15.8%53.5M-14.4%62.5M+0.1%
Operating lease liability (total)107M+7.3%100M+75.3%57.2M-12.3%65.2M-11.8%73.9M
Finance lease liability (total)
———5.66M—
Finance lease liability
———3.57M—
Other non-current liabilities70.0K+218.2%22.0K-99.1%2.49M-85.4%17.0M-22.3%21.9M+168.4%
4.53B-3.4%4.69B-21.5%5.97B+415.5%1.16B-30.1%1.66B-7.8%
Common stock0.000.000.000.000.00
Additional paid-in capital5.02B+10.1%4.56B-15.5%5.40B+9.4%4.93B+11.6%4.42B+15.9%
Retained earnings-502M-532.4%116M-79.9%576M+115.3%-3.77B-36.5%-2.76B-44.1%
Accumulated other comprehensive income4.36M-53.8%9.44M+331.2%-4.08M-56.0%-2.62M-176.6%-946K-165.5%
Non-controlling interest765M+53.1%500M+4.1%480M+6.7%450M+17.8%382M+58.0%
Total equity incl. non-controlling5.29B+2.0%5.19B-19.6%6.45B+301.1%1.61B-21.2%2.04B-0.0%
Total liabilities & equity5.71B+5.0%5.44B-24.7%7.22B+202.2%2.39B-7.6%2.59B-0.2%
Common shares issued720M+3.5%696M-13.7%807M+6.1%760M+9.4%695M+6.7%
Common shares outstanding720M+3.5%696M-13.7%807M+6.1%760M+9.4%695M+6.7%
Shares outstanding (cover)719M+5.8%680M-8.0%739M-3.7%767M+9.4%701M
Cash Flowas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
-750M+10.6%-839M-9.7%-765M+9.3%-843M-24.4%-678M-22.7%
Depreciation & amortization3.35M-76.2%14.1M-36.1%22.0M+16.9%18.9M+217.9%5.93M
Share-based compensation346M+19.8%289M+44.8%200M-8.3%218M-61.5%565M+565.0%
Deferred income taxes0.000.000.000.000.00
-682M+61.4%-1.77B-133.9%5.20B+11854.6%-44.3M-114.6%303M+1056.7%
Capital expenditure8.21M+78.5%4.60M+232.8%1.38M-89.1%12.7M-27.2%17.4M+200.3%
Free cash flow-759M+10.1%-844M-10.1%-767M+10.4%-856M-23.1%-695M-24.6%
Acquisitions0.000.000.00—0.00
Sales/maturities of investments1.12B0.000.000.00-100.0%320M
Other investing activities2.52M+3287.3%-79.0K+99.1%-8.59M-1123.9%-702K-17.0%-600K
134M+111.0%-1.22B-390.9%419M-16.0%499M+62.8%307M-32.8%
Long-term debt issued0.00—0.00——
Long-term debt repaid
0.00————
Common stock issued0.000.00-100.0%200M-36.0%312M0.00
Common stock repurchased—1.29B0.000.00—
Dividends paid0.000.00—0.000.00
Other financing activities———0.00+100.0%-1.56M
FX effect on cash——616K-90.2%6.28M0.00
Net change in cash-1.29B+66.2%-3.82B-178.7%4.86B+1372.1%-382M-464.6%-67.6M
Interest paid0.00-100.0%5.96M-41.9%10.3M+93.6%5.30M-4.2%5.54M+174.4%
Income taxes paid48.4M-21.9%61.9M+401.1%12.4M+140.9%5.13M+459.8%916K-77.5%
Valuation Ratiosas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Market cap20.0B+184.2%7.02B-17.3%8.49B+50.1%5.66B+64.8%3.43B-46.1%
P/E
——1.9×——
P/S2415.7×+899.5%241.7×—179.5×+189.0%62.1×-76.8%
P/B4.4×+194.2%1.5×+7.4%1.4×-71.5%4.9×+135.9%2.1×-41.5%
Earnings yield
——52.6%——
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2026Matthew Gline$3.1M$382.4M$38.3M$561.00$145.00
FY2025Matthew Gline$163.3M$120.3M$55M$204.00$104.00
FY2024Matthew Gline$738.2K$45.5M$4.7M$213.00$108.00
FY2023Matthew Gline$49M$97.6M$48.7M$149.00$100.00

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: ROIV’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ROIV filings on SEC EDGAR → Not investment advice.